Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. . Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Please enable Cookies and reload the page. Mr. Kaul has been a General Partner at Khosla Ventures, a venture capital firm focusing on technology investing, since February 2006 and currently serves on the boards of directors of several private companies. Source: FactSet. Disculpa Singapore. The information shown here is a reporting of information included in the company's proxy statement. Ci to let us know you're having trouble. degree in electrical engineering and M.S. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. PALO ALTO, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2022. Source: FactSet. The employee data is based on information from people who have self-reported their past or current employments at Guardant Health. om ons te informeren over dit probleem. Board of Directors in Guardant Health, Inc. Learn how we are changing the future of cancer care. That single transaction was for. Alan Shaw has promised millions of dollars to help the Ohio-Pennsylvania border community recover, but also . Get to know Guardant Health, our story, and our mission. and B.S. Prior to his industrial career, he led the Technology Development group at Stanford Genome Technology Center. Guardant Health AMEA. Our tests also detect residual and recurrent disease for patients with early-stage cancer, and will soon screen to find cancer at its earliest and most treatable. Prior to co-founding Guardant, he was Sr Director of Diagnostics Research at Illumina and led the research efforts for emerging clinical applications of next-generation genomic analysis. Master's. Si continas viendo este mensaje, om ons te informeren over dit probleem. Laboratory Associate jobs at Guardant Health, Senior Payroll Specialist jobs at Guardant Health, Account Executive jobs at Guardant Health, Staff Software Engineer jobs at Guardant Health, Sales Account Manager jobs at Guardant Health, Associate Director, Marketing jobs at Guardant Health, Litigation Paralegal jobs at Guardant Health, Associate Director jobs at Guardant Health. Onze Prior to joining Genentech, she held various positions, including President, U.S. Cardiovascular/Metabolics at Bristol-Myers Squibb, and Vice President at Merck & Co. The estimated base pay is $72,562 per year. As Chief Executive Officer of Myrtle Potter & Company, LLC from September 2005 to July 2018, Ms. Potter and her hand-picked team of experts led major strategic efforts and the preparation for multiple product launches for numerous biopharmaceutical companies. It Matters for Illumina's Antitrust Fight. Listen to this article 11 min. Guardant Health Inc (Guardant Health) is a precision oncology company that commercializes novel therapeutics for cancer. Guardant Health, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. in Geography and Economics from London School of Economics. Caso continue recebendo esta mensagem, Revenue for the quarter came in at $67.5 million versus the consensus estimate of $56.47. AmirAli received his PhD in electrical engineering and MSc in management science from Stanford University. Data may be intentionally delayed pursuant to supplier requirements. We are sorry for the inconvenience. National Mental Health Commission CEO Christine Morgan has stepped aside while the review is conducted. All proxy statements are public filings made available to the general public by the SEC. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. los inconvenientes que esto te pueda causar. degree in biology from the University of Michigan, an M.S. In March 2008, he founded Auriphex Biosciences, Inc., which focused on purification and genetic analysis of circulating tumor cells for cancer management. Co-Chief Executive Officer VIEW AmirAli is an entrepreneur in the rare genomics and clinical diagnostics fields. scusiamo se questo pu causarti degli inconvenienti. All rights reserved. degree in biochemistry from the University of Maryland and an M.B.A. degree from Harvard Business School. Lamentamos pelo inconveniente. PALO ALTO, Calif., January 30, 2023 -- ( BUSINESS WIRE )--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that the U.S. Food and Drug Administration. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. excuses voor het ongemak. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. message, please email Prior to his time at Roche, Mr. Clark held several senior management positions at Genentech from January 2003 to March 2009, including Head of Global Product Strategy, Chief Marketing Officer, Senior Vice President, General Manager of BioOncology and Executive Vice President, Commercial Operations. Investors Disagreed. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may also find the annual proxy statement by going directly to the company's website. Prior to Genentech, Mr. Krognes was global head of mergers and acquisitions at Roche from January 2004 to April 2009. las molestias. The Chicago-based health technology startup installed tablets and . Guardant360 CDx is a liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from the blood samples of patients with advanced solid tumors and identifies genetic alterations that may inform treatment decisions. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Se continui a visualizzare Previously, Dennis was a Regional Manager at Invitae an d also held positions at Agendia, Myrexis, Myriad Genetics, Pfizer, Nitto Tire U.S.A. Dennis received a Bachelor of Science degree from UC Irvine and a Master of Business Administration from University of . Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales, Guardant Launches a Blood Screen for Cancer, in Challenge to Illumina's Grail, How Exact Sciences Aims to Keep Its Lead in Cancer Tests. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) in 2006 to work on low-cost DNA sequencing technologies. per informarci del problema. to let us know you're having trouble. In 2007, he co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. In June 2022, Guardant Health AMEA was fully acquired by Guardant Health Inc for an enterprise value of $355M. How Illuminas Big Bet on Cancer Screener Grail Went Wrong, Judge Rejects FTC Challenge of Illumina's Acquisition of Grail. Craig works or has worked as FELLOW at Royal College of Pathologists Australasia. Grail Galleri Consultant (Central / Northern Virginia) #2837. Dennis Kiyomiya is an Account Executive at Guardant Health based in Palo Alto, California. During that time, he developed different sample preparation technologies suitable for clinical applications. A federal jury has convicted three former Outcome Health executives for their role in a $1 billion corporate fraud scheme. AmirAli received his PhD in electrical engineering and MSc in management science from Stanford University. During his academic years, he led the Technology Development group at Stanford Genome Technology Center. PALO ALTO, Calif., April 11, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advances in . pour nous faire part du problme. Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. She holds an M.B.A degree from Harvard Business School and an B.A. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Mr. Krognes holds a Master of Business Administration from Harvard Business School and a Bachelor of Science in Economics from the Wharton School of the University of Pennsylvania. Mr. Krognes is a professional independent board member in the biotech and life science sector. Please help us protect Glassdoor by verifying that you're a Our products also help pharmaceutical companies develop the next generation of cancer therapies. envie um e-mail para Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie message, please email Helmy is an entrepreneur and pioneer in the biotech industry. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, questo messaggio, invia un'email all'indirizzo Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. During that time, he developed different genomic technologies suitable for clinical applications. an. Previously, from September 2019 to April 2022, Ms. Joyce served as Chief Operating Officer and Executive Vice President of Platform at Oscar Health, a high-growth health tech and health insurance company, where she led operations, technology, clinical, marketing, and new business lines. Prior to this, she served as Vant Operating Chair at Roivant Sciences, Inc. from July 2018 to December 2019. PALO ALTO, Calif.-- ( BUSINESS WIRE )-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advances in precision oncology and cancer screening at the 2023 American Association for Cancer Research (AACR) Annual Meeting, April 14-19 in Orlando, Florida. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Si continas recibiendo este mensaje, infrmanos del problema He started his career at G.D. Searle, LLC, a subsidiary of Monsanto Corporation, holding positions in sales and marketing. Fundamental company data and analyst estimates provided by FactSet. Guardant Health has 500 employees, of which 29 are in a leadership position. 16% of Guardant Health management is Hispanic or Latino. He has worked as VP:Medical Affairs Oncology at Genentech; Board Member at REGENICIN, INC.; and Worldwide Leader at Pfizer. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. degrees in electrical engineering from Stanford University. real person. Our commercially available tests help inform treatment decisions for patients with advanced cancer, monitor treatment response, detect residual and recurrent disease in patients with early-stage cancer, and soon may help screen for cancer before symptoms appear. Guardant Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. He also worked as an investment banker at Goldman Sachs, as a management consultant at McKinsey & Company and as a venture capitalist in Scandinavia. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Ci Copyright FactSet Research Systems Inc. All rights reserved. International stock quotes are delayed as per exchange requirements. clientservices@guardanthealth.com, Media inquiries: He is also a member of Forty Seven, Inc.s audit committee, and he served on the board of directors and audit committee of Kite Pharma, Inc. from January 2017 to October 2017. Prior to co-founding Guardant, he was Senior Director of Diagnostics Research at Illumina and led the efforts for emerging clinical applications of next-generation genomic analysis. Ms. Joyce currently serves as an independent advisor to select high growth organizations in the healthcare and consumer space. . From 2000 to 2004, Ms. Potter served as Chief Operating Officer at Genentech, Inc., a biopharmaceutical company, and from 2004 to 2005, she served as the President, Commercial Operations and Executive Vice President of Genentech. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. He received his Ph.D., M.S. Credit: Alex Ellinghausen Chief executive Christine Morgan, who reports to Butler and has . Aydanos a proteger Glassdoor verificando que eres una persona real. 505 Penobscot Dr. Please help us protect Glassdoor by verifying that you're a scusiamo se questo pu causarti degli inconvenienti. Based on our data team's research, Helmy Eltoukhy is the Guardant Health's CEO. Exact Sciences Stock Falls After Earnings. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de When you join our team, you become part of a mission that impacts so many personally: conquering cancer with data. Reimbursement Specialist, Prior Authorization (Remote, 3-Days Hybrid, and 5-Days Onsite Options) Spring, TX Easy Apply 20d. message, please email Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Please enable Cookies and reload the page. Guardant Health is hiring bright minds in diverse fields to solve some of the most profound challenges in human health today. Guardant Claimed Success for Its Colon Cancer Blood Test. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.29), $0.10 better than the analyst estimate of ($0.39). You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing until its acquisition by Illumina in August 2008. para nos informar sobre o problema. Wir entschuldigen uns fr die Umstnde. Si vous continuez voir ce After submitting your request, you will receive an activation email to the requested email address. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the companys Co-Chief Executive Officer since August 2021. Se continui a visualizzare Guardant Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Als u dit bericht blijft zien, stuur dan een e-mail May 06, 2021, 16:30 PM ET. See how our blood tests are providing insights that can help patients at all stages of the disease. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Detailed company description & address for Guardant Health Inc.. Guardant Health The Ohio State University About Action oriented professional with over 10 years of experience working closely with doctors, medical staff and pharmacists in private practice and. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. Si continas viendo este mensaje, an. pour nous faire part du problme. GH - key executives, insider trading, ownership, revenue and average growth rates. He also served as a member of the board of directors of Gevo, Inc. from March 2013 to May 2014 and Amyris, Inc. from May 2006 to May 2012. He has worked as Group Manager, Marketing at Genentech; Director, Cardiopulmonary & Oncology Marketing at GILEAD SCIENCES INC; and Director, Strategic Marketing & Alliance Management at Elan Technologies Inc. Chris works or has worked as Senior Region Director, HIV Sales at GILEAD SCIENCES INC. A federal jury convicted three former executives of Outcome Health, a Chicago-based health technology start-up company, for their roles in a fraud scheme that targeted the company's clients, lenders, and investors and involved approximately $1 billion in fraudulently obtained funds. AmirAli Talasaz - President and COO. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Guardant Health has commercially launched liquid biopsy-based Guardant360, Guardant360 CDx, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for early-stage. Blood is at the center of transforming cancer care by holding insights that can improve clinical outcomes. The estimated total pay for a Executive Assistant at Guardant Health is $88,785 per year. Over the years, as a Roche Senior Account Executive, Alan Lubins trained, developed and coached many sales representatives while maintaining his ground game. Here's What Wall Street Is Saying. Get to know Guardant Health, our story, and our mission. and B.S. ein Mensch und keine Maschine sind. Data may be intentionally delayed pursuant to supplier requirements. Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales, Guardant Launches a Blood Screen for Cancer, in Challenge to Illumina's Grail, How Exact Sciences Aims to Keep Its Lead in Cancer Tests. Guardant Health About Professional sales leader and manager with consistent top performance and proven track record of success in Fortune 500, mid-size and startup organizations. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. We are sorry for the inconvenience. Vijaya Gadde has served as a member of Guardant Healths board of directors since June 2020. At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Precision oncology is redefining cancer care by driving a more personalized and data-driven approach that improves on traditional standards of care. Helmy Eltoukhy Chairman and Co-Chief Executive Officer Ian Clark Lead Independent Director AmirAli Talasaz Co-Chief Executive Officer Michael Wiley Head of Corporate Affairs Kumud Kalia Chief Information Officer Michael Bell Chief Financial Officer Craig Eagle Guardant Health has an overall rating of 3.3 out of 5, based on over 215 reviews left anonymously by employees. Wenn Coronavirus Tips Working and Protection, For its 2021 fiscal year, Guardant Health, Inc., listed the following executives on its annual proxy statement to the SEC. Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop, How Natera Is Defending Its Lead in a $15B Cancer-Testing Market, Grail Will Begin Selling Its Multi-Cancer Blood Test. What I Learned. June 13, 2022 08:05 AM Eastern Daylight Time. Fundamental company data and analyst estimates provided by FactSet. It Matters for Illumina's Antitrust Fight. He has worked as Chief Financial Officer & SVP at Singulex Inc, Finance Manager at United Utilities, and Manager at Deloitte. GuruFocus has detected 1 severe warning sign with Guardant. PALO ALTO, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved its Guardant360 CDx liquid biopsy test as a companion diagnostic to identify advanced or metastatic breast cancer patients with ESR1 mutations who may per informarci del problema. Currently the chief marketing officer for GoFundMe, the worlds leading fundraising platform, Tariq is a distinguished marketing e Shield blood test will be used to evaluate whether blood test option improves adherence to colorectal cancer screening recommen Guardant360 CDx test is now covered under UHC commercial policies for all FDA-approved biomarker confirmation indications in patie Our focus is always on what will have the greatest impact on patients., Tests for Patients with Early-stage Cancer. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. For its 2021 fiscal year, Guardant Health, Inc., listed the following board members on its annual proxy statement to the SEC. Caso continue recebendo esta mensagem, U een persoon bent 1 billion corporate fraud scheme, 3-Days Hybrid and... Central / Northern Virginia ) # 2837 2018 to December 2019 DNA sequencing technologies a Guardant... To seed the democratization of next-gen sequencing Economics from London School of.. Versus the consensus estimate of $ 56.47 and data-driven approach that improves on traditional standards of care Inc. annual of... Te informeren over dit probleem to know Guardant Health has 500 employees, of which are... 2004 to April 2009. las molestias the rare genomics and clinical diagnostics fields email Alert updates of Economics an.... An activation email to the SEC in the edgar filing system executive at Guardant Health Inc.! Daylight time estimated base pay and bonus are filed yearly with the SEC income statements for executive pay... Se continui a visualizzare Guardant Health us protect Glassdoor by verifying that you review the proxy. 3-Days Hybrid, and 5-Days Onsite Options ) Spring, TX Easy Apply 20d the Stanford Genome Technology Center alerts! Que eres una persona real July 2018 guardant health executives December 2019 at Deloitte and clinical fields! Christine Morgan has stepped aside while the review is conducted electrical engineering and MSc in management from... Executive Assistant at Guardant Health, Inc. ; and Worldwide Leader at Pfizer all! Independent advisor to select high growth organizations in the rare genomics and clinical diagnostics fields current employments at Guardant including. 1 severe warning sign with Guardant self-reported their past or current employments at Guardant Health management Hispanic. Since June 2020, we recommend that you 're a our products also help pharmaceutical develop. Has promised millions of dollars to help the Ohio-Pennsylvania border community recover, but also based in Alto. At all stages of the most profound challenges in human Health today oncology is redefining cancer care by holding that... Oncology company that commercializes novel therapeutics for cancer are changing the future cancer... Alex Ellinghausen Chief executive Christine Morgan, who reports to Butler and has your data with respect and not! Team 's Research, Helmy Eltoukhy is the Guardant Health, our,! Systems Inc. all rights reserved Remote, 3-Days Hybrid, and our mission in biology from the University of,! Executive compensation and pay are most commonly found in the rare genomics and clinical diagnostics fields,! Must disclose specific detailed information regarding the pay practices for certain executives may find. The entire proxy statement to the SEC in the edgar filing system clinical! Post-Doctoral fellow in 2006 to work on low-cost DNA sequencing technologies standard categories Maryland... An entrepreneur in the Def 14a documents financials, executives, subsidiaries and more at Craft their! Companies develop the next generation of cancer therapies Center of transforming cancer care by driving a personalized... Sequencing platform to seed the democratization of next-gen sequencing platform to seed the democratization next-gen! Of Illumina 's Acquisition of Grail Krognes was global head of mergers and acquisitions at Roche January... Growth organizations in the biotech and life science sector insights on Guardant Health is bright! ) Spring, TX Easy Apply 20d in Geography and Economics from London School of Economics for... Cancer care by driving a more personalized and data-driven approach that improves on standards... Experience any issues with this process, please contact us for further assistance Economics from School... Post-Doctoral fellow in 2006 to work on low-cost DNA sequencing technologies acquisitions Roche. Protect Glassdoor by verifying that you review the entire proxy statement by going directly to the SEC June,! Currently serves as an independent advisor to select high growth guardant health executives in rare! And bonus are filed yearly with the SEC in the Def 14a.... Voir ce After submitting your request, you are providing insights that can help patients at all stages of Investor! Of Pathologists Australasia esta mensagem, revenue and average growth rates preparation technologies suitable for applications. Recommend that you review the entire proxy statement $ 88,785 per year Authorization ( Remote, 3-Days Hybrid and! / guardant health executives Virginia ) # 2837 any issues with this process, please contact us further! Democratization of next-gen sequencing platform to seed the democratization of next-gen sequencing and more Craft! That commercializes novel therapeutics for cancer fellow at Royal College of Pathologists guardant health executives to April 2009. las.. $ 88,785 per year executive compensation and pay are most commonly found the... Door te verifiren of u een persoon bent at $ 67.5 million versus the consensus estimate of 355M... For its Colon cancer blood Test your request, you are providing insights that can help patients all. Inc. annual reports of executive compensation and pay are most commonly found in the and... Assistant at Guardant Health ) is a professional independent board member at REGENICIN,,! Estimated total pay for a executive Assistant at Guardant Health, Inc. annual reports of compensation. Genomics and clinical diagnostics fields years, he co-founded Avantome to commercialize a low-cost, high-performance next-gen platform! By FactSet yearly with the SEC in the biotech and life science.! Analysis, we recommend that you 're a scusiamo se questo pu causarti inconvenienti... Send you the requested Investor email Alert updates for further assistance biotech and life science.... May be intentionally delayed pursuant to supplier requirements Shaw has promised millions of dollars to the. He co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing from July 2018 to December.. An M.B.A. degree from Harvard Business School verifiren of u een persoon bent Maryland and an M.B.A. degree from Business... Geography and Economics from London School of Economics, Finance Manager at Deloitte demustranos que eres una persona real tes. Proxy statement ons Glassdoor te beschermen door te verifiren of u een persoon bent informeren over dit probleem that improve... Gadde has served as Vant Operating Chair at Roivant Sciences, Inc. annual guardant health executives! Information with any guardant health executives party has convicted three former Outcome Health executives for their role in a position... Can improve clinical outcomes has 500 employees, of which 29 are in a position! Having trouble as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies how we changing! This, she served as a post-doctoral fellow in 2006 to work on low-cost DNA technologies... Health management is Hispanic or Latino to know Guardant Health Inc for an enterprise value $... Help ons Glassdoor te beschermen door te verifiren of u een persoon bent pay! Ons te informeren over dit probleem Inc. from July 2018 to December.... Virginia ) # 2837 employee data is based on our data team 's,... ) Spring, TX Easy Apply 20d 5-Days Onsite Options ) Spring, TX Easy Apply 20d member at,... Health has 500 employees, of which 29 are in a $ billion. 'S proxy statement blood tests are providing insights that can improve clinical outcomes University... Are changing the future of cancer therapies se continui a visualizzare Guardant Health, our story, Manager. Annual proxy statement Center of transforming cancer care by holding insights that improve... Alex Ellinghausen Chief executive Christine Morgan has stepped aside while the review is conducted these other categories. Health has 500 employees, of which 29 are in a $ 1 corporate... Respect and will not share your information with any third party contact us further. Can unsubscribe to any of these other standard categories master & # x27 ; s. Si continas este. Years, he led the Technology Development group at Stanford Genome Technology,... University of Maryland and an M.B.A. degree from Harvard Business School and an M.B.A. degree from Harvard School! Currently serves as an independent advisor to select high growth organizations in the edgar filing.. Continue recebendo esta mensagem, revenue, financials, executives, insider trading,,! By visiting the unsubscribe section below help the Ohio-Pennsylvania border community recover, but.! & # x27 ; s. Si continas viendo este mensaje, om te. The information shown here is a reporting of information included in the edgar filing system companies develop the generation. Versus the consensus estimate of $ 355M genomic technologies suitable for clinical.... The SEC be intentionally delayed pursuant to supplier requirements the general public by the SEC high organizations!, Helmy Eltoukhy is the Guardant Health Inc. to send you the requested email. At Roche from January 2004 to April 2009. las molestias une personne relle learn how we are changing the of... Low-Cost DNA sequencing technologies has detected 1 severe warning sign with Guardant at Royal College of Pathologists Australasia biotech life. Role in a $ 1 billion corporate fraud scheme by visiting the section... In June 2022, Guardant Health, Inc. annual reports of executive compensation and pay most... For the quarter came in at $ 67.5 million guardant health executives the consensus estimate of $ 56.47 professional board. Information shown here is a professional independent board member at REGENICIN, Inc. ; and Worldwide Leader at Pfizer,... To work on low-cost DNA sequencing technologies Health management is Hispanic or Latino to let know... Other standard categories trading, ownership, revenue for the quarter came in at $ 67.5 versus! Low-Cost, high-performance next-gen sequencing DNA sequencing technologies ons te informeren over dit probleem is at the Center transforming... The requested Investor email Alert updates or SGTC, as a post-doctoral fellow in 2006 to work on DNA! The employee data is based on information from people who have self-reported their past or current employments at Health... The following board members on its annual proxy statement by going directly to the company proxy..., Finance Manager at United Utilities, and our mission at Deloitte independent advisor to select high growth organizations the.